[ad_1]
Tuesday's commissioners focused mainly on the clinical trial, in which patients were enrolled before giving their consent, although they were able to withdraw after the fact.
RELATED: Hennepin County Commissioners Hear about the Use of Ketamine by Hennepin Healthcare
"There is nothing unusual about Hennepin Healthcare's research perspective, we respect all the rules and regulations that govern research," said Dr. William Heegaard, Chief Medical Officer. to the commissioners.
KSTP
He added: "We do not interfere with a drug in a situation where we would not normally have taken medication, which is a very important point for our community."
RELATED: Outraged community members demand answers in sedation controversy
Heegaard has listed other steps that Hennepin Healthcare will now take, including asking a state regulator to conduct a formal review, as well as calling on a national expert to do the same.
Yet his explanation did not allay the concerns of some of the community members present.
RELATED: Minneapolis City Council members call for completion of sedation case investigation
"We have to stand on the right side and not give drugs to people without their consent," Toya Woodland said afterwards.
A bioethics expert from the University of Minnesota, Dr. Carl Elliott, was also present. When asked what he thought about Heegaard's explanation, Mr. Elliott said that he believed that the ketamine study violated federal guidelines in the area of ketamine. because of consent issues.
Heegaard told the commissioners that he would be back at a later date with additional information.
Source link
